Chihong Heidi Zhou (Chihong Zhou)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Chronic Myeloid Leukemia

Top Venues

Molecular cancer therapeutics

Autopsy & case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin overcomes resistance to tyrosine kinase inhibitors in patient-derived, oncogene-driven lung adenocarcinoma models. Molecular cancer therapeutics (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Guofeng Gao, Amir Qorbani, Chihong Heidi Zhou
A pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) (NET and undifferentiated carcinoma of the pancreas with osteoclast-like giant cells) with metastatic neuroendocrine component to the liver. Autopsy & case reports 11 (2020)